Gisbert, Javier-P; Donday, María-G; Riestra, Sabino; Lucendo, Alfredo-J; Benítez, José-Manuel; Navarro-Llavat, Mercè; Barrio, Jesús; Morales-Alvarado, Víctor-J; Rivero, Montserrat; Busquets, David; Leo-Carnerero, Eduardo; Merino, Olga; Nantes-Castillejo, Óscar; Navarro, Pablo; Van-Domselaar, Manuel; Gutiérrez, Ana; Alonso-Abreu, Inmaculada; Mejuto, Rafael; Fernández-Salazar, Luis; Iborra, Marisa; Martín-Arranz, María-Dolores; Pineda, Juan-Ramón; Sampedro, Manuela-Josefa; Serra-Nilsson, Katja; Bouhmidi, Abdel; Batista, Lissette; Muñoz-Villafranca, Carmen; Rodríguez-Lago, Iago; Ceballos, Daniel; Guerra, Iván; Manosa, Miriam; Marín-Jiménez, Ignacio; Torrella-Cortés, Emilio; Vera-Mendoza, Maribel; Casanova, María-José; de-Francisco, Ruth; Arias-González, Laura; Marín-Pedrosa, Sandra; García-Bosch, Orlando; García-Alonso, Francisco-Javier; Delgado-Guilléna, Pedro; García, María-José; Torrealba, Leyanira; Núñez-Ortiz, Andrea; Vicuna-Arregui, Miren; Bosca-Watts, Marta-Maia; Blázquez-Gómez, Isabel; Acosta, Diana; Garre, Ana; Baldan, Montse; Martínez, Concepción; Barreiro-de-Acosta, Manuel; Domenech, Eugeni; Esteve, María; García-Sánchez, Valle; Nos, Pilar; Panes, Julián; Chaparro, María
(BMJ PUBLISHING GROUP, 2024-12-01)
BACKGROUND AND OBJECTIVES: Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) and immunomodulators who withdraw anti-TNF ...